glp1gradedGLP-1 provider ratings

Grade notice. No grade is published anywhere on this site: the weights are provisional and are not signed off, so no letter grade, weighted total or ranking appears on any page.

How many GLP-1 sellers publish a price

Every GLP-1 seller this research could find had its own pages opened and read — 588 companies, 1886 pages. Fewer than one in seven published a price a reader can put beside another seller’s. This page is the count, and the rule applied at each step that narrows it.

Ellis Brandt built this site’s grading methodology and maintains it. Last re-read September 2026.

What was read, and how

588 sellers, 1886 pages opened between them, of which 1737 rendered and 149 did not. On the pages that rendered, 3317 dollar figures were captured; 299 of those were the same figure appearing again, leaving 3018 distinct published figures. Every one was read on a single day, September 2026.

A figure counts as published only if a reader can see it. A number that sits in a page’s markup and never displays is counted as absent, and a panel a reader can open counts as published, because a control that reveals text is a reader reaching it. Each figure was then classified by a person reading the words around it — no parser decided what kind of number it was.

3 companies in the original read are excluded from every number on this page: one was the reading’s own control rather than a seller, and two are domains that no longer resolve to the companies they name. A domain that changed hands cannot be reported as that company’s page.

There is one reading behind this page and no second one. Nothing here describes a change, a trend or a price movement, because there is nothing to compare against — only one day’s reading exists.

Where the reading landed

Each of the 588 sellers falls into exactly one of six outcomes. The six sum to 588; nothing was dropped for being inconvenient, including the sellers whose sites would not render for this reading at all.

What the reading found, across 588 GLP-1 sellers

Share of the 588 sellers whose pages were opened. Each seller is counted once, in one outcome.

  1. No page rendered

    13 of 588

    Counted as read and reported, not dropped. A site that would not render is a gap in this reading, not a finding about the company.

  2. No visible figure anywhere

    50 of 588

  3. Figures in markup only

    29 of 588

    Presence is not publication: text a reader never sees is counted as absent. A collapsed panel a control opens would have rendered on open and been counted as published.

  4. Figures, but none tied to a GLP-1

    88 of 588

    A figure with nothing near it naming a drug cannot be shown to price that drug. This counts what could be tied, not what the company sells.

  5. No standing monthly rate

    210 of 588

    A one-off charge, a prepay total, an introductory price or a floor is a number, but not a rate that recurs.

  6. A standing monthly rate

    198 of 588

Read from each seller’s own public pages, September 2026. Counted from the research corpus this site is built on; see how we grade.

180 of the 588 published nothing this reading could tie to a GLP-1 — either no visible figure at all, or figures with nothing near them naming one of these drugs. That is a statement about what could be shown, not a claim those companies sell nothing: a price with no drug named beside it cannot be proved to be that drug’s price, and this site would rather report the gap than guess across it.

From every seller read to the ones with a comparable price

The same 588 sellers, narrowed one rule at a time. Each step below is a subset of the one above it.

From 588 sellers read to 60 whose figure states what it buys

Sellers, out of the 588 whose pages were opened. Each rung is a subset of the rung above it.

  1. Pages opened and read

    588

  2. At least one page rendered

    575 of 588

  3. Published a figure tied to a GLP-1

    408 of 588

  4. Published a standing monthly rate

    198 of 588

    A one-off charge, a prepay total, an introductory price or an advertised floor is a number, but it is not a rate that recurs.

  5. That rate is comparable with another seller's

    117 of 588

    It names semaglutide or tirzepatide, it was read on a page scoped to that drug, and the amount is unambiguous. These are the sellers with a page on this site.

  6. The figure states what dose it buys

    60 of 588

    The only sellers this site prints a price for. The other 57 have a page that states what was read and why no figure is shown.

Every rung computed from the same corpus reading, September 2026. The last two are the sets this site’s boards and prices are built on.

60 of 588 is 10 per cent. That is the honest size of the comparable GLP-1 market as its own websites describe it — not the size of the market, which is far larger, but the share of it that published a number a buyer can weigh against another number.

The three narrowings, and the rule each applies

Three rules do almost all of the narrowing, and each one is a decision about what can be shown rather than a judgement of a company.

A figure has to be tied to a drug. 408 sellers cleared this and 180 did not. The test is whether the drug is named on the page the figure was read on, or in the text immediately around it. A price on a page that never says what it is for is a price about which nothing can be said.

A rate has to recur. 210 of the 408 publish figures tied to a GLP-1 without any of them being a standing monthly rate. A prepay total for three months and a monthly rate are different quantities, and putting them in one column would be the comparison this site exists to refuse.

The rate has to name a molecule, on that molecule’s own page. 81 sellers publish a standing monthly rate this site still cannot compare, because the figure names a GLP-1 without saying which, or names a brand-name product, or was read on a general page rather than a page scoped to the drug. What drug a GLP-1 price is for counts that in full, across every published figure rather than one per seller.

The reasons overlap: a seller can fail two of these tests with the same figure. So this section states each rule and its two counts rather than splitting the difference into a chart, which would sum past its own denominator while looking like a partition.

What this count is not

The three sets on this page, and what each one is

  1. Sellers whose pages were opened

    588 of 588 — The reading, not the market. A company nobody could find was not read.

  2. Sellers with a page on this site

    117 of 588 — Every seller publishing a comparable standing monthly rate has a page here, priced or not.

  3. Sellers this site prints a price for

    60 of 588 — Only a figure that states what dose it buys is printed. The rule does not bend.

Computed from the same corpus reading, September 2026.

This is not a market size. It counts companies whose sites could be found and opened, and a seller that advertises nowhere a reader can reach was never in the count. It is not a ranking either: no company is named on this page, and no letter grade, score or order of merit is published anywhere on this site while the weights behind them are provisional.

It is also not a price comparison. Not one dollar figure appears above, and the module this page reads carries none — 2608 of the 3018 figures read are not a comparable monthly rate, and a great many were read on pages that never say which drug they price. Where prices are printed on this site they come from the 60 sellers whose figure states what it buys, each one shown with the seller’s own words for what the money covers.

The roster page for every one of the 117 sellers with a comparable rate is under every seller we have read, including the 57 that carry no price and say why. What is counted, and what each measurement is worth, is on how we grade.

The other findings

Each is counted over its own set, and the sets are different sizes on purpose. The denominator is printed beside every one.

Where the comparable sellers are compared

One board per buying decision, built from the 117 sellers above whose rate is comparable.